Announcements Trials

Browse Landscape

Phase

Phase 3 2 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Burkitt Lymphoma 1

Interventions

pembrolizumab 514 Specimen Handling 382 Carboplatin 372 Magnetic Resonance Spectroscopy 333 Cisplatin 327 Nivolumab 303 Cyclophosphamide 295 Radiotherapy 255 Paclitaxel 252 Biopsy 235 Gemcitabine 231 Bevacizumab 212 Dexamethasone 167 durvalumab 162 Oxaliplatin 160 Capecitabine 155 Rituximab 152 Fluorouracil 148 venetoclax 143 Docetaxel 143 atezolizumab 141 Drug Therapy 140 Etoposide 139 Doxorubicin 131 Ipilimumab 126 Radiosurgery 118 Prednisone 117 Lenalidomide 117 Leucovorin 111 fludarabine 109

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × CVAD protocol × 1 year × Clear all

NCT07564453 2026-05-04

FLOW

The First Affiliated Hospital of Soochow University

Phase 2 Recruiting

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡